Bacteriophages for the Treatment of Graft Infections in Cardiovascular Medicine
Open Access
- 25 November 2021
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 10 (12) , 1446
Abstract
Bacterial infections of vascular grafts represent a major burden in cardiovascular medicine, which is related to an increase in morbidity and mortality. Different factors that are associated with this medical field such as patient frailty, biofilm formation, or immunosuppression negatively influence antibiotic treatment, inhibiting therapy success. Thus, further treatment strategies are required. Bacteriophage antibacterial properties were discovered 100 years ago, but the focus on antibiotics in Western medicine since the mid-20th century slowed the further development of bacteriophage therapy. Therefore, the experience and knowledge gained until then in bacteriophage mechanisms of action, handling, clinical uses, and limitations were largely lost. However, the parallel emergence of antimicrobial resistance and individualized medicine has provoked a radical reassessment of this approach and cardiovascular surgery is one area in which phages may play an important role to cope with this new scenario. In this context, bacteriophages might be applicable for both prophylactic and therapeutic use, serving as a stand-alone therapy or in combination with antibiotics. From another perspective, standardization of phage application is also required. The ideal surgical bacteriophage application method should be less invasive, enabling highly localized concentrations, and limiting bacteriophage distribution to the infection site during a prolonged time lapse. This review describes the latest reports of phage therapy in cardiovascular surgery and discusses options for their use in implant and vascular graft infections.Keywords
This publication has 66 references indexed in Scilit:
- Satellite phage TLCφ enables toxigenic conversion by CTX phage through dif site alterationNature, 2010
- Microbial Pathogenesis and Biofilm Development2004
- In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm resultsJournal of Vascular Surgery, 2003
- Mechanisms of antibiotic resistance in bacterial biofilmsInternational Journal of Medical Microbiology, 2002
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000
- An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challengeCardiovascular Surgery, 1998
- Mechanism of late prosthetic vascular graft infectionCardiovascular Surgery, 1997
- An analysis of two prevalence surveys of nosocomial infection in German intensive care unitsJournal of Hospital Infection, 1997
- Infected Arterial GraftsAnnals of Surgery, 1975
- Infection in Arterial Reconstruction with Synthetic GraftsAnnals of Surgery, 1972